Back
Snap, Inc. Vs. Rigel Pharmaceuticals, Inc. Industry Stock Comparison
Sell
49
SNAP
Snap, Inc.
Last Price:
$7.91
Seasonality Move:
4.17%
Buy
75
RIGL
Rigel Pharmaceuticals, Inc.
Last Price:
$42.35
Seasonality Move:
10.06%
Sell
49
Snap, Inc. (SNAP)
is a Sell
Is Snap, Inc. a Buy, Sell or Hold?
-
The current Snap, Inc. [SNAP] share price is $8.03. The Score for SNAP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
SNAP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Rigel Pharmaceuticals, Inc. (RIGL)
is a Buy
Is Rigel Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rigel Pharmaceuticals, Inc. [RIGL] share price is $43.40. The Score for RIGL is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
RIGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SNAP Stock Price Chart
What is Snap, Inc.'s stock price today?
-
The Snap, Inc. share price today is $8.03The current trend is relatively stagnant and SNAP is experiencing buying pressure, which is a positive indicator for future bullish movement.
RIGL Stock Price Chart
What is Rigel Pharmaceuticals, Inc.'s stock price today?
-
The Rigel Pharmaceuticals, Inc. share price today is $43.40The current trend is moderately bearish and RIGL is experiencing slight selling pressure.
SNAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 53.56 | Buy |
| Chaikin Money Flow: | 30598877 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.55 - 8.43) | Buy |
| Bollinger Bands (100): | (7.22 - 8.8) | Buy |
RIGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.25 | Buy |
| Relative Strength Index (14 RSI): | 51.59 | Buy |
| Chaikin Money Flow: | -95586 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.37 - 48.61) | Buy |
| Bollinger Bands (100): | (26.12 - 42.24) | Buy |
SNAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.74 | Buy |
| 20-day SMA: | 8.04 | Sell |
| 50-day SMA: | 7.97 | Buy |
| 200-day SMA: | 8.36 | Sell |
| 8-day EMA: | 7.83 | Buy |
| 20-day EMA: | 7.88 | Buy |
| 50-day EMA: | 7.94 | Buy |
| 200-day EMA: | 8.63 | Sell |
RIGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.5 | Sell |
| 20-day SMA: | 44.71 | Sell |
| 50-day SMA: | 35.76 | Buy |
| 200-day SMA: | 26.75 | Buy |
| 8-day EMA: | 46.51 | Sell |
| 20-day EMA: | 44.13 | Sell |
| 50-day EMA: | 38.93 | Buy |
| 200-day EMA: | 29.2 | Buy |
Snap, Inc. Earnings Growth & SNAP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.15 per share.
Rigel Pharmaceuticals, Inc. Earnings Growth & RIGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.13 per share, and a decrease next year of $2.31 per share.
Snap, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rigel Pharmaceuticals, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||